Fineline Cube

Follow:
14409 Articles
CSPC's SYH2056 Wins NMPA Nod for Depression Trials as Fast‑Acting 5‑HT2A Agonist
Others

CSPC’s SYH2056 Wins NMPA Nod for Depression Trials as Fast‑Acting 5‑HT2A Agonist

Biokin's iza-bren NDA Accepted for Nasopharyngeal Carcinoma, Advancing Bispecific ADC
CompanyDrug

Biokin’s iza-bren NDA Accepted for Nasopharyngeal Carcinoma, Advancing Bispecific ADC

Phrontline Raises $60M Series Pre‑A+ to Advance Bispecific ADC Pipeline
CompanyDeals

Phrontline Raises $60M Series Pre‑A+ to Advance Bispecific ADC Pipeline

Valo Health Partners with Merck on $3B Parkinson's Disease Discovery Deal
CompanyDeals

Valo Health Partners with Merck on $3B Parkinson’s Disease Discovery Deal

NMPA Issues Export Drug Certification Rules, Expanding Scope and Validity
Policy / Regulatory

NMPA Issues Export Drug Certification Rules, Expanding Scope and Validity

Bayer's HYRNUO Wins FDA Approval for HER2-Mutated Lung Cancer
CompanyDrug

Bayer’s HYRNUO Wins FDA Approval for HER2-Mutated Lung Cancer

Johnson & Johnson China PINS Head Alex He to Depart, Driving Leadership Transition Amid Key NRDL Product Success
Company

Johnson & Johnson China PINS Head Alex He to Depart, Driving Leadership Transition Amid Key NRDL Product Success

3SBio's Mandi Spin-Off Targets HKEX IPO as Hair Health Leader
CompanyDeals

3SBio’s Mandi Spin-Off Targets HKEX IPO as Hair Health Leader

GE HealthCare to Acquire Intelerad for $2.3B, Expanding Cloud-Enabled Imaging
CompanyDeals

GE HealthCare to Acquire Intelerad for $2.3B, Expanding Cloud-Enabled Imaging

Sinovac Receives Nasdaq Delisting Notice Over Late 20-F Filing
Company

Sinovac Receives Nasdaq Delisting Notice Over Late 20-F Filing

Pien Tze Huang's PZH2108 Cancer Pain Drug Enrolls First Phase IIa Patient
CompanyDrug

Pien Tze Huang’s PZH2108 Cancer Pain Drug Enrolls First Phase IIa Patient

Abbott to Acquire Exact Sciences for $21B, Entering Cancer Diagnostics Leadership
CompanyDeals

Abbott to Acquire Exact Sciences for $21B, Entering Cancer Diagnostics Leadership